Arxis Reports Today With Bulls in Clear Control

Arxis, Inc. steps into its earnings release today with short sellers already gone and analysts pointing firmly higher — the print is now the only remaining test of a clean bull setup.

The positioning picture is unusually one-sided. Short interest has dropped nearly 20% over the past week, continuing the retreat documented in yesterday's note, and availability remains loose at 559% — roughly five-and-a-half shares available for every one borrowed, well clear of the 52-week floor near 283%. Borrow cost has ticked up modestly to 0.87% on the week but remains near the bottom of its recent range. Options traders are equally relaxed: the put/call ratio of 0.11 barely nudges above its 20-day average and is nowhere near the 0.82 peak hit over the past year. There is no defensive hedging, no squeeze pressure, no residual short overhang. Across every positioning signal, the market is leaning long into the release.

Analysts have been unanimous in the same direction. Every firm that has updated targets since the May IPO — Citigroup, Wells Fargo, and Morgan Stanley among them — raised price objectives, with the consensus mean landing at $52.80 against a current price of $42.47. That implies roughly 24% upside from here. Bulls point to a diverse U.S. customer base, strong IPO momentum, and 2026 guidance that has already drawn fresh institutional money: T. Rowe Price, Vanguard, and Columbia all initiated positions as recently as June 30. The bear case is narrower — slower-than-expected growth, a heavy reliance on the Mechanical Components segment, and potential defense sector headwinds that could cap the margin story. RBC's more cautious Sector Perform rating, with a $46 target well below the Street average, captures that skepticism in one number.

The historical reaction data offers one useful anchor. After the last earnings event in May, the stock jumped more than 13% on the day and held most of that gain over the following week. That print established high expectations. Today's release is therefore less a test of whether Arxis can grow and more a test of whether guidance can hold up at a valuation — 51.7x trailing earnings and 26x EV/EBITDA — that already prices in a great deal of that optimism.